Form 8.3 - UDG Healthcare plc

RNS Number : 1724D

Schroders PLC

25 June 2021

 

Ap19

FORM   8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.  KEY   INFORMATION

Nameofpersondealing (Note 1)	Schroders PLC
Companydealtin	UDG Healthcare PLC
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)	€0.05 ordinary shares
Date of dealing	2021-06-24

2.  INTERESTS AND SHORT POSITIONS

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

	Long			Short
	Number		(%)	Number			(%)
(1)Relevantsecurities	3,568,306.00		1.4164	0.00		0.00
(2) Derivatives (other than options)	0.00		0.00	0.00		0.00
(3)Optionsandagreementstopurchase/sell	0.00		0.00	0.00		0.00
Total	3,568,306.00		1.4164	0.00		0.00

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:	Long			Short
	Number		(%)	Number		(%)
(1)Relevantsecurities
(2) Derivatives (other than options)
(3)Optionsandagreementstopurchase/sell
Total

Ap20

1.  DEALINGS  (Note   4)

(a)  Purchases and sales

Purchase/sale	Numberofrelevantsecurities	Priceperunit (Note 5)
Purchase	247,501	10.426856 GBP

(b)  Derivatives transactions (other than options transactions)

Productname, e.g. CFD	Natureoftransaction (Note 6)	Numberofrelevantsecurities (Note 7)	Priceperunit (Note 5)

(c)  Options transactions in respect of existing relevant securities

(i)  Writing, selling, purchasing or varying

Productname, e.g. call option	Writing, selling,purchasing,varyingetc.	Numberofsecurities towhichtheoptionrelates (Note 7)	Exercise price	Type, e.g.American,Europeanetc.	Expiry date	Optionmoney paid/receivedperunit (Note 5)

(ii)  Exercising

Productname, e.g. call option	Numberofsecurities	Exercisepriceper unit (Note 5)

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.  OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other 

person relating to the voting rights of any relevant securities under any option referred to on this form or relating 

to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to which any derivative referred 

to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?  (Note   9)    YES/NO

Dateofdisclosure	2021-06-25
Contact name	Schroders Shareholding Disclosure Team
Telephone number	[phone]
If aconnectedEFM,nameofofferee/offerorwithwhichconnected
If aconnectedEFM,statenatureofconnection (Note 10)

 

END

 

 

ISEDKPBNKBKDBAB